Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 21, Number 1—January 2015


Epidemiology of Human Plague in the United States, 1900–2012

CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at; (4) view/print certificate.

Release date: December 10, 2014; Expiration date: December 10, 2015

Learning Objectives

Upon completion of this activity, participants will be able to:

•     Analyze the broad epidemiology of human plague in the United States

•     Identify the most common primary clinical form of human plague in the United States

•     Evaluate temporal trends in the epidemiology of human plague

•     Assess survival outcomes of human plague in the United States.

CME Editor

Jean Michaels Jones, BSN, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Jean Michaels Jones has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Clinical Professor of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed the following financial relationships: served as an advisor or consultant for McNeil Pharmaceuticals.


Disclosures: Kiersten J. Kugeler, PhD, MPH; J. Erin Staples, MD, PhD; Alison F. Hinckley, PhD; Kenneth L. Gage, PhD; and Paul S. Mead, MD, MPH, have disclosed no relevant financial relationships. Dr Kugeler, Dr Hinckley, and Dr Mead reported they intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.


Article Navigation